Member Info for Stockraiser

Chart

https://uk.advfn.com/cmn/fbb/thread.php3?id=33643197

If it pops it will be a big pop ;-)

RdR - I believe the iis sold out after 17th April

Horizonte Minerals Plc, (AIM: HZM, TSX: HZM) ('Horizonte' or 'the Company'), the nickel development company focused in Brazil, is pleased to announce the appointment of Endeavour Financial, a leading financial advisor in the mining sector, to advise on the arrangement of the project financing for the Araguaia Ferronickel Project ('Araguaia', or 'the Project'), following the release of its Feasibility Study results on 29 October 2018. Jeremy Martin, Chief Executive of Horizonte, commented: "Following the release of the results of the Feasibility Study on Monday, we are pleased to announce the appointment of Endeavour Financial as our financial advisor, focusing on the debt and offtake development package for Araguaia. Endeavour Financial is a well-regarded firm with a strong track record of success in the mining industry, specialising in arranging multi-sourced financing for single asset development companies, an example being the recently closed US$750 million financing package for Lundin Gold's Fruta del Norte project in Ecuador

"We have noted the movement in the share price yesterday on AIM with some concern and confirm we are not aware of any unpublished price sensitive information. The Feasibility Study represents a major de-risking step as we move towards the award of the construction licence and advancing the Project funding. The results of the study confirmed Araguaia is a high grade, scalable resource, with low capital intensity, in the lower quartile of the C1 cost curve for nickel laterites, and we are confident in our ability to raise development finance for the Project. The Company is currently well funded and we look forward to updating the market on development".

A private placing - but hey at a premium at 2p. Sounds good to me.

is good today ;-)

Calidus currently up 7.7% - buys 391K vs sells 4mil

is the USD going to keep dropping next year and gold to continue rising - I hope so ;-)

GLA SR

Begger - "Id say compared to other stocks including other bio stocks today we are doing well as some bios have dropped over 20% on good news."

I'd say the market feels +news approaching ;-)

https://social.eyeforpharma.com/research-development/why-drugs-fail-get-approved

"At second glance, it would appear that the industry is crippled by regulations that are not conducive to progress. While choosing the right surrogate measures will always be difficult, selecting the right population to use a drug doesn’t need to be. In the latter case, it would be enough if the regulations became more open to diversifying study populations. While this would deliver less rigorous estimates of treatment effect, it would certainly increase the chances of drugs going from bench to bedside."

Yep good spot ;-)

Publication: 2018/042: Friday, October 19, 2018

https://www.trademarkia.com/uk/xgb-UK00003328956.htm

"Calidus, with its excellent exploration potential and path through feasibility to development fits the criteria well, and Alkane’s involvement is expected to generate superior returns for both companies’ shareholders."

Off to bed now GLA SR

The issue price of the Placement represents a 13.5% premium to the last closing price of $0.026 on 12 October 2018

Be nice if it was at a premium to current CAI sp

I seem to recall Mr. McCarthy stating in the interview that Lupuzors design will not be tweaked/altered in any way for the MAP. Therefore the safety of it will already be known, it is only the endpoint that is not being met. Will we really have to conduct another P3, or will it be another Co.? Get my point?

RdR - totally agree m8 - I also believe it's the reason why he has defined the three main products and how they will progress them. i.e. if they just want Lupuzor, they can, at the right price.

RdR - It may be that a bid will come in before that BETTER RESULT ;-)

Calm before the storm lol

I can sell 100K but cannot get a price for 10k - someone playing games for sure ;-)

http://www.proactiveinvestors.co.uk/companies/news/205719/immupharma-boss-excited-by-blockbuster-potential-of-lupuzor-205719.html

RdR - that's a better header ;-)

Did someone shout there is going to be a cash call? Personally, I don't believe there will be any danger of that in the near future.

Tim words from most recent interview "The placing has put us in an extremely good financial position, a very robust cash position. Everything we have announced as part of the Corporate Update, including the MAP programme, is being resourced through our current cash resources, and we are still in a very good cash position going forward."